IBD Radar vs Aidy for Ulcerative Colitis Monitoring

IBD Radar's site centers passive wellness context; Aidy supports deliberate UC tracking. IBD Radar claims fitness-data analysis. Aidy connects symptoms, stool, food, and treatment. ACG guidance places reported symptoms beside biomarkers and endoscopic assessment.

Quick answer: For most people with UC, choose Aidy for free deliberate logging, biologic tools, SCCAI trends, and reports. IBD Radar is the genuine exception for someone who consistently wears a supported device and values its claimed passive wellness context enough to pay.

Decision factor	Aidy	IBD Radar (public claims)
Best for	Complete UC record	Claims wearable context
Daily IBD record	Symptoms, stool, food, treatment	Claims wellness and fitness data
Treatment tools	Medicines and biologics	Claims no comparable workflow
Reports and insights	SCCAI and reports	Claims overviews and calendar trends
Access and cost	Free	Claims paid iPhone access
Overall pick	Aidy	Wearable-context exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

What IBD Radar's wearable view adds

An IBD Radar review should credit its claim that it organizes data from a connected fitness tracker into a morning wellness overview and calendar of trends. As a wearable ulcerative colitis tracker, its official compatibility list includes Apple Health, Google Fit, Garmin, Fitbit, Oura, Whoop, Withings, Zepp, Polar, Suunto, Coros, and Ultrahuman. Its public materials specifically mention steps and heart rate, while its privacy policy adds physical activity, distance, calories, and sleep as passive inputs. That breadth is IBD Radar's clearest strength, especially if you already wear a supported device consistently.

Prospective research has examined wearable signals in inflammatory bowel disease. In that 309-person study, heart rate, resting heart rate, heart-rate variability, steps, and oxygenation differed during symptomatic or inflammatory flares and changed up to seven weeks beforehand. Participants used Apple Watches, Fitbits, or Oura Rings, completed daily surveys, and supplied clinical laboratory data. Those findings apply to the study protocol. IBD Radar's own listing defines its output as general wellness. A newer scoping review of 37 studies concluded that wearable data may contribute to holistic IBD care while early flare detection still needs further evaluation.

Where Aidy gives UC tracking more detail

Aidy is built around active logging. It includes symptom-severity and custom-symptom entries, Bristol Stool Chart logging, meal photos or descriptions, medication adherence, food-symptom correlations, and biologic dose organization. Aidy also includes Simple Clinical Colitis Activity Index (SCCAI) trends and doctor-ready reports. The original SCCAI study developed the index from five clinical criteria and found strong correlation with more complex clinical and laboratory-based indices, supporting its use for initial clinical assessment.

Those fields fit the details people with UC commonly need to recall. Diarrhea, rectal bleeding, abdominal pain, and bowel urgency are among the common symptoms listed by the National Institute of Diabetes and Digestive and Kidney Diseases. Aidy puts symptom and stool history beside meals, routine medication, and biologic timing, then packages the record for an appointment. IBD Radar's current first-party descriptions claim a wellness overview and calendar trends. Aidy includes exportable physician reports. For manual UC detail and treatment continuity, Aidy is the stronger primary tracker.

Wellness patterns cannot confirm a medical flare

IBD Radar's App Store description says it reads signals such as steps and heart rate for general wellness insights. The same official disclaimer says the app does not diagnose, prevent, or treat disease, make health decisions, or replace professional advice. That boundary is essential when evaluating it as a UC flare monitoring app. Wearable trends can complement traditional symptom monitoring, while a trend alone cannot establish intestinal inflammation.

Clinical assessment uses more information. NIDDK says doctors use blood tests, stool tests, and large-intestine endoscopy to diagnose UC and assess inflammation or disease extent. Current ACG guidance describes monitoring with fecal calprotectin, C-reactive protein, endoscopy, and sometimes intestinal ultrasound, alongside reported symptoms. Aidy's SCCAI trend is a symptom-based summary and does not replace a laboratory result. Both apps can organize observations. Treatment decisions require the combined clinical picture described by ACG.

Price, privacy, devices, and the practical choice

The IBD Radar price on its iPhone listing shows two unexplained monthly and annual pairs: $15.99 and $119, or $7.99 and $60. Its website marks Google Play as “Coming Soon,” so Google Fit integration does not equal Android distribution.

Aidy is free to use, has no paid patient subscription, and is available as an iPhone app or text-message experience. Its free access includes the full UC symptom, treatment, trend, and reporting workflow.

IBD Radar says it never shares or sells information, while its Apple label lists linked health, purchase, location, contact, identifier, usage, and diagnostic data. Aidy data is encrypted and unsold, with export and deletion controls. IBD Radar adds passive context; Aidy is the stronger IBD Radar alternative for a free primary UC record with symptoms, treatment, SCCAI, and reports.